Article Information
vol. 10 no. 449
- Received for publication August 21, 2017
- Resubmitted February 24, 2018
- Accepted for publication June 22, 2018
Author Information
- Marian Major1,*,
- Alexander Gutfraind2,3,†,
- Louis Shekhtman2,4,†,
- Qingwen Cui1,
- Alla Kachko1,
- Scott J. Cotler2,
- Behzad Hajarizadeh5,
- Rachel Sacks-Davis6,7,
- Kimberly Page8,
- Basmattee Boodram3 and
- Harel Dahari2,*
- 1Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.
- 2Program for Experimental and Theoretical Modeling, Division of Hepatology, Department of Medicine, Loyola University Chicago, Maywood, IL 60153, USA.
- 3Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL 60612, USA.
- 4Department of Physics, Bar-Ilan University, Ramat Gan 52990, Israel.
- 5The Kirby Institute, University of New South Wales, Sydney, New South Wales 2052, Australia.
- 6Disease Elimination Program, Burnet Institute, Melbourne, Victoria 3004, Australia.
- 7Department of Medicine, University of Melbourne, Parkville, Victoria 3010, Australia.
- 8Division of Epidemiology, Biostatistics and Preventive Medicine, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
- ↵*Corresponding author. Email: marian.major{at}fda.hhs.gov (M.M.); hdahari{at}luc.edu (H.D.)